Metagenomi Therapeutics News and Activities

Metagenomi Therapeutics is a company listed under the stock ticker MGX (US).

Acquisition, funding and merger involving Metagenomi Therapeutics.

• The new name of Metagenomi is Metagenomi Therapeutics. (posted on January 13 2026).

View the org chart displaying its 32 main executives

Most searched biographies at Metagenomi Therapeutics

• Jian Irish, Chief Executive Officer
• Brian Thomas, Director
• Jürg Eckhardt, Director

Popular executive movements at Metagenomi Therapeutics

• Brian Thomas who was Chief Executive Officer and Director, becomes Director  (posted on November 13 2025).
• Jian Irish, who was Chief Operating Officer and Director, is promoted to Chief Executive Officer  (posted on November 13 2025).
• Sarah Noonberg, Chief Medical Officer, has left the company  (posted on September 11 2025).

Create your alert
to follow the executive moves at Metagenomi Therapeutics.

Metagenomi Therapeutics has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Metagenomi Therapeutics

• Metagenomi Announces Publication of Data in Nature Communications Describing Novel, Ultra-Small Nucleases for Gene Editing - Metagenomi
• After blazing trails in RNA-targeted drugs, Ionis jumps into gene editing
• Ionis Partners with Metagenomi to Add Gene Editing to its Broad Technology Platform - Metagenomi
• Mining (and Refining) the Stuff of Gene Editing Tools
• Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies - Metagenomi
• Metagenomi Announces Participation in October Investor and Industry Conferences - Metagenomi
• The Meta(nuclease)verse: Metagenomi Is Developing the Next Generation of Gene-Editing Therapies
• Metagenomi Named an Endpoints 11 Winner - Metagenomi
• Metagenomi Announces Participation in September Investor and Industry Conferences - Metagenomi
• Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients - Metagenomi
• View more press releases Close

Social media about Metagenomi Therapeutics

• Metagenomi Therapeutics on Wikipedia, Google News & Yahoo Finance
• Metagenomi Therapeutics on LinkedIn, X (Twitter) & YouTube